EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

11421 reported adverse events

Drug classes: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

These side effects are most commonly reported by patients taking EMTRICITABINE AND TENOFOVIR ALAFENAMIDE:

# Side effect Count
0 BONE DENSITY DECREASED 4869
1 CHRONIC KIDNEY DISEASE 2890
2 BONE LOSS 2649
3 OSTEONECROSIS 2620
4 MULTIPLE FRACTURES 2442
5 TOOTH LOSS 2330
6 OSTEOPOROSIS 2283
7 RENAL FAILURE 2267
8 PAIN 2017
9 EMOTIONAL DISTRESS 1925
See all common reactions for EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE DEMINERALISATION 240 0.2266
1 BONE LOSS 2649 0.1760
2 SKELETAL INJURY 1632 0.1577
3 BONE DENSITY DECREASED 4869 0.1552
4 MULTIPLE FRACTURES 2442 0.1485
5 TOOTH LOSS 2330 0.1123
6 OSTEOPENIA 1516 0.0998
7 BONE DENSITY ABNORMAL 337 0.0901
8 TOOTH INJURY 379 0.0872
9 PROTEIN TOTAL ABNORMAL 111 0.0853
See all enriched reactions for EMTRICITABINE AND TENOFOVIR ALAFENAMIDE